. Author manuscript; available in PMC: 2022 Feb 9.

Published in final edited form as: Expert Rev Vaccines. 2017 Dec 29;17(2):145–161. doi: 10.1080/14760584.2018.1418665

Table 6.

Probiotic supplementation by rotavirus vaccine IgA seroconversion.

Reference	Location	Income group^b	Vaccine	No of Doses	Measured outcomes	Supplementation with LGG®		p-Value
Reference	Location	Income group^b	Vaccine	No of Doses	Measured outcomes	Yes	No	p-Value
Lazarus et al. 2017 [127]	India	LM	RV1	2	IgA seroconversion rate	39%^a	27%	0.04
Isolauri et al. 1995 [128]	Finland	H	RRV-S1	1	IgA seroconversion rate	93%	74%	0.05

RV1: rotarix; RRV-S1: rhesus-human reassortant monovalent serotype 1; LGG®: Lactobacillus rhamnosus.

With additional zinc supplementation.

World Bank list of economies (December 2016) low-income (L); lower middle-income (LM); upper middle-income (UM); high-income (H).